Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?
Saved in:
| Title: | Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status? |
|---|---|
| Authors: | Segers F; Laboratory of Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium., Delforge M; Laboratory of Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium. Michel.delforge@uzleuven.be.; Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. Michel.delforge@uzleuven.be. |
| Source: | Targeted oncology [Target Oncol] 2026 Jan; Vol. 21 (1), pp. 63-86. Date of Electronic Publication: 2026 Jan 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1776-260X |
|---|---|
| DOI: | 10.1007/s11523-025-01189-7 |
